Free delivery nationwide for orders above ₱800

RXDRUG-DRP-6324

Averkaz Montelukast Sodium 5mg Chewable Tablet 30's

Contact us for a price
Out of stock
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Description

Indications/Uses

Management of chronic asthma, allergic rhinitis. Prophylaxis for exercise-induced asthma.
 

Dosage/Direction for Use

Doses to be given once daily at bed time. Chewable tab Childn 6-14 yr 5 mg. FC tab Adult ≥15 yr 10 mg.
 

Administration

May be taken with or without food.
 

Contraindications

Hypersensitivity. Hepatic impairment or cirrhosis.
 

Special Precautions

Not indicated for use in acute asthma attacks. Not to be used as monotherapy for the treatment & management of exercise-induced bronchospasm. Pregnancy & lactation. Childn <2 yr.
 

Adverse Reactions

GI disturbances, dry mouth, thirst; hypersensitivity reactions including anaphylaxis, angioedema & skin reactions; asthenia, dizziness, irritability, restlessness, headache, sleep disorders (insomnia, drowsiness, nightmares); upper resp tract infection, fever, arthralgia, myalgia.
 

Drug Interactions

Potent CYP450 enzyme inducers eg, phenobarb or rifampin.
 

MedsGo Class

Antiasthmatic & COPD Preparations

Features

Dosage
5 mg
Ingredients
  • Montelukast
Packaging
Chewable Tablet 30's
Generic Name
Montelukast Sodium
Registration Number
DRP-6324
Classification
Prescription Drug (RX)
Find similar

Product Questions

Questions
 
 
 
--> -->